Cannabis Europa 2024 Mainstage E1 | The impact of cannabis rescheduling: Market implications for Germany and the USA with Arthur De Cordova, CEO of Ziel
This quarter two seismic shifts occurred in the United States and Germany with a common denominator: the DEA advanced the rescheduling of cannabis from a narcotic to a Class III drug in the USA, and Germany completed the rescheduling with passage of the Cannabis Reform Law April 1. However, the implications are different for the two largest cannabis markets. Join us for a fireside chat with Arthur de Cordova, a former Country Manager for AstraZeneca in Europe, and CEO of Ziel.
Business of Cannabis: Cannabis News | Cannabis Views | Cannabis Trends
Audio is streamed directly from the publisher (chrt.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.